Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Kenneth Kirby"'
Autor:
Lorenzo Galluzzi, Jenny Zilberberg, Amelia Zellander, Kenneth Kirby, Christopher Uhl, Christopher Cultrara, Essam Abed Elrazaq, David W Andrews, Charles B Scott, Mark A Exley
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 8 (2023)
Background IGV-001 is a personalized, autologous cancer cell-based immunotherapy conceived to deliver a tumor-derived antigenic payload in the context of immunostimulatory signals to patients with glioblastoma (GBM). IGV-001 consists of patient-deriv
Externí odkaz:
https://doaj.org/article/4dcff276a1bf4922837be3e5877e9195
Autor:
David Andrews, Mark Exley, Charles Scott, Jenny Zilberberg, Amelia Zellander, Kenneth Kirby, Christopher Uhl, Christopher Cultrara
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/20e397c8f37e4e6e9cd181847ee0c01d
Autor:
Amelia Zellander, Christopher Uhl, Christopher Cultrara, Kenneth Kirby, Essam Elrazaq, Charles Scott, David Andrews, Jenny Zilberberg, Mark Exley
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Christopher Cultrara, Kenneth Kirby, Essam Elrazaq, Christopher Uhl, Amelia Zellander, Lorenzo Galluzzi, Mark Exley, Jenny Zilberberg
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Christopher Cultrara, Kenneth Kirby, Essam Elrazaq, Christopher Uhl, Amelia Zellander, Lorenzo Galluzzi, Mark Exley, Jenny Zilberberg
Publikováno v:
Cancer Research. 83:1812-1812
Background: Imvax is developing a novel personalized immunotherapy platform that combines whole-tumor derived cells with an antisense oligonucleotide against insulin-like growth factor 1-receptor in implantable biodiffusion chambers (BDCs; 0.1 μm po
Autor:
Christopher N. Cultrara, Amelia Zellander, Charles E. Scott, Kenneth Kirby, Christopher Uhl, Mark A. Exley, Jenny Zilberberg, David W. Andrews
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundIGV-001 is a novel immunotherapy that combines irradiated, patient-derived glioblastoma tumor cells and an antisense oligonucleotide against insulin-like growth factor type 1 receptor (IMV-001) in biodiffusion chambers (0.1-micron pore size
Autor:
Jenny Zilberberg, Amelia Zellander, Christopher Uhl, Christopher Cultrara, Kenneth kirby, Essam Elazaq, Charles B. Scott, David W. Andrews, Mark Exley
Publikováno v:
Cancer Research. 82:626-626
Background: IGV-001 is a novel immunotherapy that combines irradiated patient-derived glioblastoma tumor cells and an antisense oligonucleotide against insulin-like growth factor type 1 receptor (IMV-001) in biodiffusion chambers (BDC). We recently r
Autor:
R. Kenneth Kirby
Publikováno v:
The Oral History Review. 35:22-28
In this article, the author argues that many of the best practices of oral history refl ect phenomenological thinking even though practitioners may not describe themselves as using phenomenological methods. The author suggests that knowledge and appl
Publikováno v:
Physiotherapy Research International. 12:136-146
Background and Purpose. Physiotherapists develop clinical reasoning theo- ries and applied manual therapy skills through a variety of educational exposures. No studies have assessed the importance of selected theories such as the convex-concave rule,
Autor:
R. Kenneth Kirby
Publikováno v:
The Journal of Continuing Higher Education. 52:36-43